Negara: Taiwan
Bahasa: China
Sumber: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
FACTOR VIII;;VWF: Rco
醫療財團法人台灣血液基金會 台北市中正區南海路3號3樓 (01010553)
B02BD02
凍晶乾燥注射劑
VWF: Rco (2012102600) I.U.; FACTOR VIII (8004003300) I.U.
瓶裝;;瓶裝
菌 疫
限由醫師使用
CSL BEHRING GMBH EMIL-VON-BEHRING STRASSE 76,35041 MARBURG GERMANY DE
coagulation factor VIII
1.當von Willebrand disease病人使用desmopressin (DDAVP)治療無效時或為其禁忌時,預防和治療病人非手術與手術造成的出血。2.預防和治療因A 型血友病而引起缺乏第八凝血因子相關之非手術與手術造成的出血。
有效日期: 2027/10/11; 英文品名: "TBSF" High Purity Factor VIII/Von Willebrand Factor Concentrate
2007-10-11
upright, attach a plastic disposable syringe to the Mix2Vial™ (transparent plastic part). Invert the system and draw the reconstituted product into the syringe by pulling the plunger back slowly. One large syringe may be used to pool several vials of reconstituted product. 2. Once the “TBSF” High Purity Factor VIII / Von Willebrand Factor Concentrate has been transferred into the syringe, firmly hold the barrel of the syringe (keeping the syringe plunger facing down) and detach the Mix2Vial™ from the syringe. Discard the Mix2Vial™ (transparent plastic part) and empty product vial in an appropriate waste container. Fit the syringe to a suitable injection needle to administer the reconstituted product. Do not use the Mix2Vial™ for injection. 3. Give the dose slowly by the intravenous route (usually within 5 to 6 minutes, or as tolerated by the patient). The injection/infusion rate should not exceed 6 mL per minute and the patient should be observed carefully during administration. If there is any reaction that might be related to the administration of “TBSF” High Purity Factor VIII / Von Willebrand Factor Concentrate, the rate of injection should be decreased or if needed, the application should be stopped (see section 4.4: Special warnings and precautions for use). 4. When the contents of more than one vial are to be given, it will be convenient to pool the total amount prior to administration (e.g. in a large syringe or sterile bag). This must be done aseptically. 5. To reduce microbiological hazard, use as soon as practicable after reconstitution/ preparation. For use in surgery, the conditions described under Continuous infusion can apply. This product is for single use only and any unused portion remaining in the vial must be discarded appropriately. 6. The solution must not be added or mixed with any other fluids to be given, including whole blood. Medical personnel, family carers and patients should be adequately trained in the techniques for the preparation and the administration of “TBSF Baca dokumen lengkapnya